Free Trial
The Market Does Not Wait. MarketBeat All Access Alerts for $149
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Get the Alerts
Claim MarketBeat All Access Sale Promotion
NASDAQ:CBUS

Cibus Q3 2026 Earnings Date & Estimates

Cibus logo
$1.38 -0.02 (-1.08%)
Closing price 10/27/2026 04:00 PM Eastern
Extended Trading
$1.38 0.00 (0.00%)
As of 10/27/2026 07:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cibus is estimated to report Q3 2026 earnings on Thursday, November 12, 2026, after market closes. The conference call is scheduled for 4:30 PM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call
4:30 PM ET

What Analysts Expect from Cibus in Q3 2026

Cibus is expected to post earnings of -$0.2033 per share on revenue of $1.30 million. In the same quarter a year earlier Cibus reported -$0.44 per share on revenue of $615 thousand. Cibus last reported on August 13, 2026, posting -$0.29 per share and missing the -$0.19 consensus estimate. Cibus has beaten the consensus EPS estimate in 3 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.2033
Expected Revenue
$1.30 million
Prior-Year EPS
-$0.44
Prior-Year Revenue
$615 thousand
Expected Revenue Growth
+111.4%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.29 (Missed by -$0.10)
Last Quarter Revenue
$994 thousand
EPS Beat Rate
3 of last 8 quarters

Cibus Q3 2026 Earnings FAQ

Cibus (NASDAQ:CBUS) is estimated to report Q3 2026 earnings on Thursday, November 12, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Cibus' Q3 2026 earnings conference call is scheduled for Thursday, November 12, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Cibus to post earnings of -$0.2033 per share for Q3 2026.

The consensus revenue estimate for Cibus is $1.30 million for Q3 2026.

Cibus Earnings Headlines

Cibus (NASDAQ:CBUS) Stock Rating Lowered by Wall Street Zen
Financial legend: “This is bad, really bad...”
Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leading Weiss Ratings, the only conflict-free rating agency in the US. Now he says a $3 trillion problem could trigger a chain reaction of crashes and failures, causing a global freeze in financial markets.tc pixel
See More Cibus Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cibus? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cibus and other key companies, straight to your email.

About Cibus

Cibus (NASDAQ:CBUS) (NASDAQ: CBUS) is an agricultural biotechnology company focused on developing gene-edited crop traits. Its technology is designed to improve the performance, resilience and sustainability of important crops by making targeted changes to plant genetics without introducing foreign DNA.

The company’s proprietary Rapid Trait Development System (RTDS) supports the development of traits for crops including canola, rice, soybeans and wheat. Cibus has pursued applications such as herbicide tolerance, pod-shatter reduction and resistance to diseases and other environmental stresses, with the goal of helping growers improve yields, reduce crop losses and use agricultural inputs more efficiently.

Cibus serves the global agriculture industry through relationships with seed companies, growers and other participants in the crop-development and commercialization ecosystem. The company became publicly traded under the Cibus name following its combination with Calyxt in 2023, bringing together Cibus’ gene-editing platform and Calyxt’s plant biotechnology capabilities.

View Cibus Profile